Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

Consolidation of physician practices, largely driven by health systems, has motivated policy efforts to move care toward lower-price, non–health system settings. At the same time, however, private ...

Almost 50 million Americans—disproportionately in rural areas—must drive 25 miles or more to access a gastroenterologist for diagnosis and treatment of issues involving the digestive system, according ...

Dr Reshma Rakshit, a Doctify rated consultant gastroenterologist, says one in four adults in the UK suffer from heartburn and acid reflux. The conditions are two of the most common digestive ...

Some of the best stomach exercises for stronger abs include crunches, teasers, planks, and body-weight squats. A workout that includes these moves can maximize a limited schedule and leave your ...

In a report released today, David Saxon from Needham maintained a Hold rating on Globus Medical (GMED – Research Report). The company’s shares opened today at $92.41. Leverage the power of ...

you should consider Globus Medical (GMED). This company, which is in the Zacks Medical - Instruments industry, shows potential for another earnings beat. This medical device company has seen a ...

Globus Medical (GMED) has agreed to buy Nevro (NVRO) through an all-cash deal valued at around $250M. Read more here.

The company currently has its sales operations distributed across 51 counties worldwide. GMED boasts a Growth Style Score of A and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating.

The Key Advances in Gastroenterology & Hepatology collection offers a unique series of specially commissioned ‘Year in Review’ articles that highlight the key discoveries made each year.